Table 2

Clinical characteristics of At-Risk progressors at 12 months

Clinical criteriaBaseline12 months
(n=19)(n=19)
Mucocutaneous
 ACLE or SCLE5/19 (26%)13/19 (68%)
 Mucosal ulcers2/19 (11%)8/19 (42%)
 Alopecia04/19 (21%)
Musculoskeletal
 Synovitis9/19 (47%)18/19 (95%)
Haematological
 Leucopaenia or lymphopenia3/19 (16%)7/19 (37%)
 Thrombocytopenia01/19 (5%)
Glandular signs06/19 (32%)
Serositis
 Pleural effusion01/19 (5%)
Renal
 Class III nephritis01/19 (5%)
  • ACLE, acute cutaneous lupus erythematosus; SCLE, sub-acute cutaneous lupus erythematosus.